364 related articles for article (PubMed ID: 11526158)
1. Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples.
Joyanes P; del Carmen Conejo M; Martínez-Martínez L; Perea EJ
J Clin Microbiol; 2001 Sep; 39(9):3247-53. PubMed ID: 11526158
[TBL] [Abstract][Full Text] [Related]
2. Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition Breakpoints.
Bobenchik AM; Deak E; Hindler JA; Charlton CL; Humphries RM
J Clin Microbiol; 2017 Feb; 55(2):450-456. PubMed ID: 27881616
[TBL] [Abstract][Full Text] [Related]
3. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China].
Wang H; Chen MJ;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):385-90. PubMed ID: 12820914
[TBL] [Abstract][Full Text] [Related]
4. In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan.
Hsueh SC; Lee YJ; Huang YT; Liao CH; Tsuji M; Hsueh PR
J Antimicrob Chemother; 2019 Feb; 74(2):380-386. PubMed ID: 30357343
[TBL] [Abstract][Full Text] [Related]
5. [Comparison between agar dilution and three other methods for determining the susceptibility of 228 clinical isolates of non-fermenting gram-negative rods].
Gómez-Garcés JL; Aracil B; Gil Y
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):331-7. PubMed ID: 19406523
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the VITEK 2 system for rapid direct identification and susceptibility testing of gram-negative bacilli from positive blood cultures.
Ling TK; Liu ZK; Cheng AF
J Clin Microbiol; 2003 Oct; 41(10):4705-7. PubMed ID: 14532207
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates.
Ling TK; Tam PC; Liu ZK; Cheng AF
J Clin Microbiol; 2001 Aug; 39(8):2964-6. PubMed ID: 11474023
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the VITEK 2 cards for identification and antimicrobial susceptibility testing of non-glucose-fermenting Gram-negative bacilli.
Hsieh WS; Sung LL; Tsai KC; Ho HT
APMIS; 2009 Apr; 117(4):241-7. PubMed ID: 19343822
[TBL] [Abstract][Full Text] [Related]
9. Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06.
Livermore DM; Hope R; Brick G; Lillie M; Reynolds R;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii55-63. PubMed ID: 18819980
[TBL] [Abstract][Full Text] [Related]
10. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
Zarakolu P; Hasçelik G; Unal S
Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial susceptibility of phenotypically extended spectrum beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii isolates].
Metan G; Zarakolu P; Hasçelik G; Akova M
Mikrobiyol Bul; 2006; 40(1-2):23-8. PubMed ID: 16775953
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of 12 broad-spectrum agents tested against 270 nosocomial blood stream infection isolates caused by non-enteric gram-negative bacilli: occurrence of resistance, molecular epidemiology, and screening for metallo-enzymes.
Jones RN; Pfaller MA; Marshall SA; Hollis RJ; Wilke WW
Diagn Microbiol Infect Dis; 1997 Nov; 29(3):187-92. PubMed ID: 9401811
[TBL] [Abstract][Full Text] [Related]
13. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001.
Karlowsky JA; Draghi DC; Jones ME; Thornsberry C; Friedland IR; Sahm DF
Antimicrob Agents Chemother; 2003 May; 47(5):1681-8. PubMed ID: 12709340
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods.
Swenson JM; Killgore GE; Tenover FC
J Clin Microbiol; 2004 Nov; 42(11):5102-8. PubMed ID: 15528702
[TBL] [Abstract][Full Text] [Related]
15. New species-related MIC breakpoints for early detection of development of resistance among gram-negative bacteria in Swedish intensive care units.
Hanberger H; Nilsson LE; Claesson B; Kärnell A; Larsson P; Rylander M; Svensson E; Sörberg M; Sörén L
J Antimicrob Chemother; 1999 Nov; 44(5):611-9. PubMed ID: 10552977
[TBL] [Abstract][Full Text] [Related]
16. [Antimicrobial resistance of Gram-negative bacilli isolated from 13 teaching hospitals across China].
Wang Q; Zhao CJ; Wang H; Yu YS; Zhu ZH; Chu YZ; Sun ZY; Hu ZD; Xu XL; Liao K; Xu YC; Zhang LY; Mei YN; Yang B; Ni YX
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1388-96. PubMed ID: 24025503
[TBL] [Abstract][Full Text] [Related]
17. Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia.
Delgado-Valverde M; Conejo MDC; Serrano L; Fernández-Cuenca F; Pascual Á
J Antimicrob Chemother; 2020 Jul; 75(7):1840-1849. PubMed ID: 32277821
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia.
Al Johani SM; Akhter J; Balkhy H; El-Saed A; Younan M; Memish Z
Ann Saudi Med; 2010; 30(5):364-9. PubMed ID: 20697174
[TBL] [Abstract][Full Text] [Related]
19. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
Burgess DS; Frei CR
J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group.
Jones RN; Pfaller MA; Doern GV; Erwin ME; Hollis RJ
Diagn Microbiol Infect Dis; 1998 Mar; 30(3):215-28. PubMed ID: 9572029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
